Can PSMA-Targeting PET/CT Be a Valuable Instrument to Assess the Presence of Brain Metastases in Lung Cancer Patients?: A Case Report : Clinical Nuclear Medicine

Secondary Logo

Journal Logo

Interesting Images

Can PSMA-Targeting PET/CT Be a Valuable Instrument to Assess the Presence of Brain Metastases in Lung Cancer Patients?

A Case Report

Dall'Armellina, Sara MD; Cauda, Simona MD; Duca, Sergio MD‡,§; Gasparro, Martina MD; Racca, Manuela MD

Author Information
Clinical Nuclear Medicine 48(6):p e304-e306, June 2023. | DOI: 10.1097/RLU.0000000000004675

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid